Click here to get full coverage on LGND: 2025 Analyst Day - Yahoo Finance

LGND: 2025 Analyst Day - Yahoo Finance

Click here to get full coverage on Ligand Pharmaceuticals (LGND) Valuation After Its 2026 Royalty-Focused Earnings Outlook Drives Investor Interest - simplywall.st

Ligand Pharmaceuticals (LGND) Valuation After Its 2026 Royalty-Focused Earnings Outlook Drives Investor Interest  simplywall.st

Ligand Pharmaceuticals (LGND) Valuation After Its 2026 Royalty-Focused Earnings Outlook Drives Investor Interest - simplywall.st

Click here to get full coverage on Woodstock Corp Sells 9,472 Shares of Ligand Pharmaceuticals Incorporated $LGND - MarketBeat

Woodstock Corp Sells 9,472 Shares of Ligand Pharmaceuticals Incorporated $LGND  MarketBeat

Woodstock Corp Sells 9,472 Shares of Ligand Pharmaceuticals Incorporated $LGND - MarketBeat

Click here to get full coverage on LGND Raises $9M to Make Earth Data Intuitive and Actionable - PR Newswire

LGND Raises $9M to Make Earth Data Intuitive and Actionable  PR Newswire

LGND Raises $9M to Make Earth Data Intuitive and Actionable - PR Newswire

Click here to get full coverage on Why retail investors favor LGND stock - Take Profit & Safe Capital Growth Stock Tips - Bölüm Sonu Canavarı

Why retail investors favor LGND stock - Take Profit & Safe Capital Growth Stock Tips  Bölüm Sonu Canavarı

Why retail investors favor LGND stock - Take Profit & Safe Capital Growth Stock Tips - Bölüm Sonu Canavarı

Click here to get full coverage on Craig-Hallum Maintains Ligand Pharmaceuticals(LGND.US) With Buy Rating - 富途牛牛

Craig-Hallum Maintains Ligand Pharmaceuticals(LGND.US) With Buy Rating  富途牛牛

Craig-Hallum Maintains Ligand Pharmaceuticals(LGND.US) With Buy Rating - 富途牛牛

Click here to get full coverage on Will LGND stock split attract more investors - Trade Analysis Summary & Low Risk Investment Opportunities - DonanımHaber

Will LGND stock split attract more investors - Trade Analysis Summary & Low Risk Investment Opportunities  DonanımHaber

Will LGND stock split attract more investors - Trade Analysis Summary & Low Risk Investment Opportunities - DonanımHaber

Click here to get full coverage on Exclusive: LGND wants to make ChatGPT for the Earth - TechCrunch

Exclusive: LGND wants to make ChatGPT for the Earth  TechCrunch

Exclusive: LGND wants to make ChatGPT for the Earth - TechCrunch

Click here to get full coverage on Ligand Pharmaceuticals Stock (LGND) Opinions on 2025 Investor Day and 2026 Guidance - Quiver Quantitative

Ligand Pharmaceuticals Stock (LGND) Opinions on 2025 Investor Day and 2026 Guidance  Quiver Quantitative

Ligand Pharmaceuticals Stock (LGND) Opinions on 2025 Investor Day and 2026 Guidance - Quiver Quantitative

Click here to get full coverage on Wilson Sonsini Advises LGND AI on $9 Million Financing - Wilson Sonsini

Wilson Sonsini Advises LGND AI on $9 Million Financing  Wilson Sonsini

Wilson Sonsini Advises LGND AI on $9 Million Financing - Wilson Sonsini

Click here to get full coverage on Ligand Pharmaceuticals Incorporated's (NASDAQ:LGND) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue? - Yahoo Finance

Ligand Pharmaceuticals Incorporated's (NASDAQ:LGND) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?  Yahoo Finance

Ligand Pharmaceuticals Incorporated's (NASDAQ:LGND) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue? - Yahoo Finance

Click here to get full coverage on FY2026 Earnings Forecast for LGND Issued By Zacks Small Cap - MarketBeat

FY2026 Earnings Forecast for LGND Issued By Zacks Small Cap  MarketBeat

FY2026 Earnings Forecast for LGND Issued By Zacks Small Cap - MarketBeat

Click here to get full coverage on Why LGND stock could see breakout soon - 2025 Support & Resistance & Accurate Buy Signal Notifications - DonanımHaber

Why LGND stock could see breakout soon - 2025 Support & Resistance & Accurate Buy Signal Notifications  DonanımHaber

Why LGND stock could see breakout soon - 2025 Support & Resistance & Accurate Buy Signal Notifications - DonanımHaber

Click here to get full coverage on New Analyst Forecast: $LGND Given $270 Price Target - Quiver Quantitative

New Analyst Forecast: $LGND Given $270 Price Target  Quiver Quantitative

New Analyst Forecast: $LGND Given $270 Price Target - Quiver Quantitative

Click here to get full coverage on Ligand Pharmaceuticals (NASDAQ:LGND) CFO Sells $339,711.24 in Stock - MarketBeat

Ligand Pharmaceuticals (NASDAQ:LGND) CFO Sells $339,711.24 in Stock  MarketBeat

Ligand Pharmaceuticals (NASDAQ:LGND) CFO Sells $339,711.24 in Stock - MarketBeat

Click here to get full coverage on Why LGND stock could see breakout soon - 2025 Market Sentiment & Technical Entry and Exit Alerts - DonanımHaber

Why LGND stock could see breakout soon - 2025 Market Sentiment & Technical Entry and Exit Alerts  DonanımHaber

Why LGND stock could see breakout soon - 2025 Market Sentiment & Technical Entry and Exit Alerts - DonanımHaber

Click here to get full coverage on Ligand Pharmaceuticals (NASDAQ:LGND) Trading 5.1% Higher - Time to Buy? - MarketBeat

Ligand Pharmaceuticals (NASDAQ:LGND) Trading 5.1% Higher - Time to Buy?  MarketBeat

Ligand Pharmaceuticals (NASDAQ:LGND) Trading 5.1% Higher - Time to Buy? - MarketBeat

Click here to get full coverage on Ligand Pharmaceuticals Incorporated $LGND Stock Holdings Raised by Ranger Investment Management L.P. - MarketBeat

Ligand Pharmaceuticals Incorporated $LGND Stock Holdings Raised by Ranger Investment Management L.P.  MarketBeat

Ligand Pharmaceuticals Incorporated $LGND Stock Holdings Raised by Ranger Investment Management L.P. - MarketBeat

Click here to get full coverage on Will LGND stock split attract more investors - Weekly Investment Summary & Capital Protection Trading Alerts - DonanımHaber

Will LGND stock split attract more investors - Weekly Investment Summary & Capital Protection Trading Alerts  DonanımHaber

Will LGND stock split attract more investors - Weekly Investment Summary & Capital Protection Trading Alerts - DonanımHaber

Click here to get full coverage on RBC Capital Maintains Ligand Pharmaceuticals (LGND) Outperform Recommendation - Nasdaq

RBC Capital Maintains Ligand Pharmaceuticals (LGND) Outperform Recommendation  Nasdaq

RBC Capital Maintains Ligand Pharmaceuticals (LGND) Outperform Recommendation - Nasdaq

Click here to get full coverage on Ligand Pharmaceuticals (LGND): Assessing Valuation After Strong Recent Share Price Gains - Yahoo Finance

Ligand Pharmaceuticals (LGND): Assessing Valuation After Strong Recent Share Price Gains  Yahoo Finance

Ligand Pharmaceuticals (LGND): Assessing Valuation After Strong Recent Share Price Gains - Yahoo Finance

Click here to get full coverage on Ligand (LGND) Q3 2025 Earnings Call Transcript - The Motley Fool

Ligand (LGND) Q3 2025 Earnings Call Transcript  The Motley Fool

Ligand (LGND) Q3 2025 Earnings Call Transcript - The Motley Fool

Click here to get full coverage on LGND: Target Up On Improved Growth Outlook - Yahoo Finance

LGND: Target Up On Improved Growth Outlook  Yahoo Finance

LGND: Target Up On Improved Growth Outlook - Yahoo Finance

Click here to get full coverage on Is Ligand Pharmaceuticals Stock Built to Withstand More Downside? - Trefis

Is Ligand Pharmaceuticals Stock Built to Withstand More Downside?  Trefis

Is Ligand Pharmaceuticals Stock Built to Withstand More Downside? - Trefis

Click here to get full coverage on What Makes Ligand Pharmaceuticals (LGND) an Investment Choice? - Yahoo Finance

What Makes Ligand Pharmaceuticals (LGND) an Investment Choice?  Yahoo Finance

What Makes Ligand Pharmaceuticals (LGND) an Investment Choice? - Yahoo Finance

Click here to get full coverage on LGND AI: $9 Million Secured For Improving Earth Data - Pulse 2.0

LGND AI: $9 Million Secured For Improving Earth Data  Pulse 2.0

LGND AI: $9 Million Secured For Improving Earth Data - Pulse 2.0

Click here to get full coverage on What is HC Wainwright's Forecast for LGND FY2026 Earnings? - MarketBeat

What is HC Wainwright's Forecast for LGND FY2026 Earnings?  MarketBeat

What is HC Wainwright's Forecast for LGND FY2026 Earnings? - MarketBeat

Click here to get full coverage on (LGND) Price Dynamics and Execution-Aware Positioning - news.stocktradersdaily.com

(LGND) Price Dynamics and Execution-Aware Positioning  news.stocktradersdaily.com

(LGND) Price Dynamics and Execution-Aware Positioning - news.stocktradersdaily.com

Click here to get full coverage on Norges Bank Acquires Shares of 14,073 Ligand Pharmaceuticals Incorporated $LGND - MarketBeat

Norges Bank Acquires Shares of 14,073 Ligand Pharmaceuticals Incorporated $LGND  MarketBeat

Norges Bank Acquires Shares of 14,073 Ligand Pharmaceuticals Incorporated $LGND - MarketBeat

Click here to get full coverage on Will Lower Short Interest Reshape Ligand Pharmaceuticals' (LGND) Sentiment Among Industry Peers? - simplywall.st

Will Lower Short Interest Reshape Ligand Pharmaceuticals' (LGND) Sentiment Among Industry Peers?  simplywall.st

Will Lower Short Interest Reshape Ligand Pharmaceuticals' (LGND) Sentiment Among Industry Peers? - simplywall.st

Click here to get full coverage on Citi Initiates Ligand Pharmaceuticals(LGND.US) With Buy Rating, Announces Target Price $270 - 富途牛牛

Citi Initiates Ligand Pharmaceuticals(LGND.US) With Buy Rating, Announces Target Price $270  富途牛牛

Citi Initiates Ligand Pharmaceuticals(LGND.US) With Buy Rating, Announces Target Price $270 - 富途牛牛

Click here to get full coverage on LGND: Stifel Raises Price Target to $230, Maintains 'Buy' Rating - GuruFocus

LGND: Stifel Raises Price Target to $230, Maintains 'Buy' Rating  GuruFocus

LGND: Stifel Raises Price Target to $230, Maintains 'Buy' Rating - GuruFocus

Click here to get full coverage on How Ligand Pharmaceuticals’ Strong Q3 Results and Raised Guidance May Impact LGND Investors - Yahoo Finance

How Ligand Pharmaceuticals’ Strong Q3 Results and Raised Guidance May Impact LGND Investors  Yahoo Finance

How Ligand Pharmaceuticals’ Strong Q3 Results and Raised Guidance May Impact LGND Investors - Yahoo Finance

Click here to get full coverage on LGND Raises $9M to Make Earth Data More Accessible and Actionable - Causeartist

LGND Raises $9M to Make Earth Data More Accessible and Actionable  Causeartist

LGND Raises $9M to Make Earth Data More Accessible and Actionable - Causeartist

Click here to get full coverage on LGND raises $9M to help AI models analyze geospatial data - SiliconANGLE

LGND raises $9M to help AI models analyze geospatial data  SiliconANGLE

LGND raises $9M to help AI models analyze geospatial data - SiliconANGLE

Click here to get full coverage on Here's How Much $100 Invested In Ligand Pharmaceuticals 15 Years Ago Would Be Worth Today - Sahm

Here's How Much $100 Invested In Ligand Pharmaceuticals 15 Years Ago Would Be Worth Today  Sahm

Here's How Much $100 Invested In Ligand Pharmaceuticals 15 Years Ago Would Be Worth Today - Sahm

Click here to get full coverage on How Investors Are Reacting To Ligand Pharmaceuticals (LGND) Management's Engagement Surge and Analyst Optimism - Yahoo Finance

How Investors Are Reacting To Ligand Pharmaceuticals (LGND) Management's Engagement Surge and Analyst Optimism  Yahoo Finance

How Investors Are Reacting To Ligand Pharmaceuticals (LGND) Management's Engagement Surge and Analyst Optimism - Yahoo Finance

Click here to get full coverage on LGND: Strong revenue growth and portfolio expansion drive robust five-year outlook - TradingView — Track All Markets

LGND: Strong revenue growth and portfolio expansion drive robust five-year outlook  TradingView — Track All Markets

LGND: Strong revenue growth and portfolio expansion drive robust five-year outlook - TradingView — Track All Markets

Click here to get full coverage on LGND Raises $9M in Funding - FinSMEs

LGND Raises $9M in Funding - FinSMEs

Click here to get full coverage on (LGND) as a Liquidity Pulse for Institutional Tactics - news.stocktradersdaily.com

(LGND) as a Liquidity Pulse for Institutional Tactics  news.stocktradersdaily.com

(LGND) as a Liquidity Pulse for Institutional Tactics - news.stocktradersdaily.com

Click here to get full coverage on $LGND stock is up 4% today. Here's what we see in our data. - Quiver Quantitative

$LGND stock is up 4% today. Here's what we see in our data.  Quiver Quantitative

$LGND stock is up 4% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on Royal Bank Of Canada Issues Positive Forecast for Ligand Pharmaceuticals (NASDAQ:LGND) Stock Price - MarketBeat

Royal Bank Of Canada Issues Positive Forecast for Ligand Pharmaceuticals (NASDAQ:LGND) Stock Price  MarketBeat

Royal Bank Of Canada Issues Positive Forecast for Ligand Pharmaceuticals (NASDAQ:LGND) Stock Price - MarketBeat

Click here to get full coverage on LGND Rebranding - BevNET.com

LGND Rebranding - BevNET.com

Click here to get full coverage on New Analyst Forecast: $LGND Given $231.0 Price Target - Quiver Quantitative

New Analyst Forecast: $LGND Given $231.0 Price Target  Quiver Quantitative

New Analyst Forecast: $LGND Given $231.0 Price Target - Quiver Quantitative

Click here to get full coverage on Raised 2026 Royalty Outlook and $1 Billion Plan Could Be A Game Changer For Ligand (LGND) - simplywall.st

Raised 2026 Royalty Outlook and $1 Billion Plan Could Be A Game Changer For Ligand (LGND)  simplywall.st

Raised 2026 Royalty Outlook and $1 Billion Plan Could Be A Game Changer For Ligand (LGND) - simplywall.st

Click here to get full coverage on Benchmark Maintains Ligand Pharmaceuticals (LGND) Buy Recommendation - Nasdaq

Benchmark Maintains Ligand Pharmaceuticals (LGND) Buy Recommendation  Nasdaq

Benchmark Maintains Ligand Pharmaceuticals (LGND) Buy Recommendation - Nasdaq

Click here to get full coverage on Stifel Nicolaus Boosts Ligand Pharmaceuticals (NASDAQ:LGND) Price Target to $230.00 - MarketBeat

Stifel Nicolaus Boosts Ligand Pharmaceuticals (NASDAQ:LGND) Price Target to $230.00  MarketBeat

Stifel Nicolaus Boosts Ligand Pharmaceuticals (NASDAQ:LGND) Price Target to $230.00 - MarketBeat

Click here to get full coverage on Insider Sale: Director at $LGND Sells 4,628 Shares - Quiver Quantitative

Insider Sale: Director at $LGND Sells 4,628 Shares  Quiver Quantitative

Insider Sale: Director at $LGND Sells 4,628 Shares - Quiver Quantitative

Click here to get full coverage on HC Wainwright & Co. Maintains Ligand Pharmaceuticals (LGND) Buy Recommendation - Nasdaq

HC Wainwright & Co. Maintains Ligand Pharmaceuticals (LGND) Buy Recommendation  Nasdaq

HC Wainwright & Co. Maintains Ligand Pharmaceuticals (LGND) Buy Recommendation - Nasdaq

Click here to get full coverage on New LGND TLK Show hosted by Lil’ Keke brings ‘authenticity, raw truth’ to sports conversation - Click2Houston

New LGND TLK Show hosted by Lil’ Keke brings ‘authenticity, raw truth’ to sports conversation  Click2Houston

New LGND TLK Show hosted by Lil’ Keke brings ‘authenticity, raw truth’ to sports conversation - Click2Houston

Click here to get full coverage on Ligand Pharmaceuticals Incorporated $LGND Shares Sold by Granite Investment Partners LLC - MarketBeat

Ligand Pharmaceuticals Incorporated $LGND Shares Sold by Granite Investment Partners LLC  MarketBeat

Ligand Pharmaceuticals Incorporated $LGND Shares Sold by Granite Investment Partners LLC - MarketBeat

Click here to get full coverage on Why Ligand Pharma, A Hidden Name Behind Two Big Drugs, Is Up 92% This Year - Investor's Business Daily

Why Ligand Pharma, A Hidden Name Behind Two Big Drugs, Is Up 92% This Year  Investor's Business Daily

Why Ligand Pharma, A Hidden Name Behind Two Big Drugs, Is Up 92% This Year - Investor's Business Daily

Click here to get full coverage on Benchmark Co. Maintains Ligand Pharmaceuticals(LGND.US) With Buy Rating, Maintains Target Price $220 - 富途牛牛

Benchmark Co. Maintains Ligand Pharmaceuticals(LGND.US) With Buy Rating, Maintains Target Price $220  富途牛牛

Benchmark Co. Maintains Ligand Pharmaceuticals(LGND.US) With Buy Rating, Maintains Target Price $220 - 富途牛牛

Click here to get full coverage on Ligand Pharmaceuticals Incorporated's (NASDAQ:LGND) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue? - 富途牛牛

Ligand Pharmaceuticals Incorporated's (NASDAQ:LGND) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue?  富途牛牛

Ligand Pharmaceuticals Incorporated's (NASDAQ:LGND) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue? - 富途牛牛

Click here to get full coverage on Ligand Pharmaceuticals Incorporated $LGND Shares Acquired by Universal Beteiligungs und Servicegesellschaft mbH - MarketBeat

Ligand Pharmaceuticals Incorporated $LGND Shares Acquired by Universal Beteiligungs und Servicegesellschaft mbH  MarketBeat

Ligand Pharmaceuticals Incorporated $LGND Shares Acquired by Universal Beteiligungs und Servicegesellschaft mbH - MarketBeat

Click here to get full coverage on Ligand Pharmaceuticals (LGND): Evaluating Valuation After Recent 11% Share Price Gain - simplywall.st

Ligand Pharmaceuticals (LGND): Evaluating Valuation After Recent 11% Share Price Gain  simplywall.st

Ligand Pharmaceuticals (LGND): Evaluating Valuation After Recent 11% Share Price Gain - simplywall.st

Click here to get full coverage on Biotech Company Ligand Pharmaceuticals Sets Dual Conference Schedule: Citi BioPharma and H.C. Wainwright - Stock Titan

Biotech Company Ligand Pharmaceuticals Sets Dual Conference Schedule: Citi BioPharma and H.C. Wainwright  Stock Titan

Biotech Company Ligand Pharmaceuticals Sets Dual Conference Schedule: Citi BioPharma and H.C. Wainwright - Stock Titan

Click here to get full coverage on Ligand Pharmaceuticals Incorporated $LGND Shares Sold by SG Americas Securities LLC - MarketBeat

Ligand Pharmaceuticals Incorporated $LGND Shares Sold by SG Americas Securities LLC  MarketBeat

Ligand Pharmaceuticals Incorporated $LGND Shares Sold by SG Americas Securities LLC - MarketBeat

Click here to get full coverage on Price Action: Can LGND stock beat analyst upgrades - Market Movement Recap & Capital Protection Trading Alerts - Улправда

Price Action: Can LGND stock beat analyst upgrades - Market Movement Recap & Capital Protection Trading Alerts  Улправда

Price Action: Can LGND stock beat analyst upgrades - Market Movement Recap & Capital Protection Trading Alerts - Улправда

Click here to get full coverage on Ligand Pharmaceuticals: Superb Q3/2025 With Second Guidance Raise Heralds Good Things To Come - Seeking Alpha

Ligand Pharmaceuticals: Superb Q3/2025 With Second Guidance Raise Heralds Good Things To Come  Seeking Alpha

Ligand Pharmaceuticals: Superb Q3/2025 With Second Guidance Raise Heralds Good Things To Come - Seeking Alpha

Click here to get full coverage on Who is Justice Alexander aka LGND? - Favikon

Who is Justice Alexander aka LGND?  Favikon

Who is Justice Alexander aka LGND? - Favikon

Click here to get full coverage on Dec. 9, 2025: Ligand Investor Day — Harvard Club NYC, 10:30 a.m.–12:00 p.m. ET; live webcast & replay - Stock Titan

Dec. 9, 2025: Ligand Investor Day — Harvard Club NYC, 10:30 a.m.–12:00 p.m. ET; live webcast & replay  Stock Titan

Dec. 9, 2025: Ligand Investor Day — Harvard Club NYC, 10:30 a.m.–12:00 p.m. ET; live webcast & replay - Stock Titan

Click here to get full coverage on Benchmark Co. Maintains Ligand Pharmaceuticals(LGND.US) With Buy Rating, Raises Target Price to $220 - 富途牛牛

Benchmark Co. Maintains Ligand Pharmaceuticals(LGND.US) With Buy Rating, Raises Target Price to $220  富途牛牛

Benchmark Co. Maintains Ligand Pharmaceuticals(LGND.US) With Buy Rating, Raises Target Price to $220 - 富途牛牛

Click here to get full coverage on Whale Trades: Can LGND stock weather global recession - Market Rally & AI Driven Stock Movement Reports - moha.gov.vn

Whale Trades: Can LGND stock weather global recession - Market Rally & AI Driven Stock Movement Reports  moha.gov.vn

Whale Trades: Can LGND stock weather global recession - Market Rally & AI Driven Stock Movement Reports - moha.gov.vn

Click here to get full coverage on Ligand Pharmaceuticals Announces FDA Approval of Lasix ONYU, Innovative Subcutaneous Delivery Device for Edema Treatment in Heart Failure Patients | LGND Stock News - Quiver Quantitative

Ligand Pharmaceuticals Announces FDA Approval of Lasix ONYU, Innovative Subcutaneous Delivery Device for Edema Treatment in Heart Failure Patients | LGND Stock News  Quiver Quantitative

Ligand Pharmaceuticals Announces FDA Approval of Lasix ONYU, Innovative Subcutaneous Delivery Device for Edema Treatment in Heart Failure Patients | LGND Stock News - Quiver Quantitative

Click here to get full coverage on LGND: Pelthos To Become Public Company - Yahoo Finance

LGND: Pelthos To Become Public Company  Yahoo Finance

LGND: Pelthos To Become Public Company - Yahoo Finance

Click here to get full coverage on SQ Innovation Receives FDA Approval for Lasix ONYU | LGND Stock News - Stock Titan

SQ Innovation Receives FDA Approval for Lasix ONYU | LGND Stock News  Stock Titan

SQ Innovation Receives FDA Approval for Lasix ONYU | LGND Stock News - Stock Titan

Click here to get full coverage on Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Q3 2025 Earnings Call Transcript - Insider Monkey

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Q3 2025 Earnings Call Transcript  Insider Monkey

LGND

Price Chart

Key Statistics

Technicals

About LGND

Latest News

LGND: 2025 Analyst Day - Yahoo Finance

Ligand Pharmaceuticals (LGND) Valuation After Its 2026 Royalty-Focused Earnings Outlook Drives Investor Interest - simplywall.st

Woodstock Corp Sells 9,472 Shares of Ligand Pharmaceuticals Incorporated $LGND - MarketBeat

Advanced Charts

Top Gainers

Top Losers